Cypestra-35, Dragées

7680572250046 CH-57225 Dragées

Associated product:

CYPESTRA-35 drag 3 x 21 pce
Cypestra-35, Dragées
Cypestra-35, Dragées
Cypestra-35, Dragées
1 / 3
google

Article details

Package size
3x21
Selling units
63
Measure
Dragée(s)
Galenic form
Dragées
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/06/2023
Patient information leaflet
Français
23/06/2023
Patient information leaflet
Italien
23/06/2023
Summary of Product Characteristics
Allemand
23/06/2023
Summary of Product Characteristics
Français
23/06/2023
Summary of Product Characteristics
Italien
23/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
35.0 UG Substance Wirkstoff (Principe actif)
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
41.19 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.016 MM Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.36 MG Substance HBESI

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
57225
Drug name
Cypestra-35, Dragées
Galenic form
UEBT
ATC Code
G03HB01
Authorization status
Z
Dispensing category
B
First authorization
14/06/2005
Authorization expiration date
31/12/9999
IT Number
07.09.0.
Domain
Human medicine
Field of application
Androgenisierungserscheinungen

Package details

Description (FR)
CYPESTRA-35 drag 3 x 21 pce
Description (DE)
CYPESTRA-35 Drag 3 x 21 Stk
Market launch
14/06/2005
Narcotic (BTM)
No

Other package sizes (1)

CYPESTRA-35 drag 21 pce
21 DRG
GTIN: 7680572250022
View